What Lucas Research does

Lucas Research is a privately-held clinical research site network founded in 2004 by Dr. K. Jean Lucas, a board-certified endocrinologist with fellowship training at Duke University Medical Center and over 250 completed clinical research studies. The company specializes in endocrine and metabolic disease trials, actively recruiting for studies in non-alcoholic fatty liver disease, diabetes, obesity, arthritis, celiac disease, and cholesterol/triglyceride disorders. Operations are anchored by a headquarters in Morehead City, North Carolina, with two additional regional offices in New Bern and Hickory, NC. The firm employs between 11 and 50 staff and is founder-owned with no disclosed institutional investment.

The core technical asset is a Fibroscan device providing non-invasive ultrasound-based transient elastography liver assessments, offered free to patients as both a screening service and a recruitment funnel into trials. A standard Athena-based patient portal supports participant scheduling, communication, and record access. The product portfolio comprises clinical trial execution services (the core offering), Fibroscan diagnostic imaging (a recruitment and community-engagement anchor), and the patient portal. There is no proprietary AI/ML tooling, no API surface, and no mobile application; technology footprint is conventional for a community-based research site.

Lucas Research operates a professional services revenue model: pharmaceutical sponsors and Contract Research Organizations pay the site to execute clinical protocols, while patients receive study-related medication, supplies, and testing at no charge plus per-visit stipends. The customer base is two-sided, with pharmaceutical sponsors and CROs as paying customers and patients with metabolic or chronic conditions plus healthy volunteers as the participant supply. Go-to-market combines community-led patient recruitment (volunteer forms, free health classes, Sugar Talk webinars, and events such as the DREAM Back To School Giveaway) with a dedicated Sponsors & CROs channel for trial referrals. Marketing is anchored on a blog covering diabetes management, diet, exercise, and research updates, supported by Facebook, LinkedIn, and Instagram activity and an email newsletter.

Name

Lucas Research

Legal name

Lucas Research

Website

https://lucasresearch.org

Company type

Private

Founded year

2004

Operating status

Operating

Headcount range

11–50 employees

Short description

Lucas Research is a privately-held clinical research site network founded in 2004 that specializes in endocrinology and metabolic disease trials for pharmaceutical sponsors, operating three North Carolina sites and recruiting patients via community outreach and free Fibroscan liver screenings.

Ownership category

akta.pro rank

Product category

Clinical Research Services

NAICS

Scientific Research and Development Services (5417)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Clinical Trial Site Operations & Study Coordination (HLAGACAE)

akta.pro secondary industries

Specialty Therapeutic-Area CROs (e.g., oncology/rare disease) (HLAGAAAL), Patient Recruitment, Site Feasibility & Trial Enablement CROs (HLAGAAAI)

Keywords

• Clinical research services
• Endocrinology clinical trials
• Metabolic disease research
• Fibroscan liver scanning
• Pharmaceutical trial site

Headquarters

HQ city

Morehead City

HQ country

United States

HQ region

North America

Offices3 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Clinical Trial Services: Lucas Research conducts clinical trials on behalf of pharmaceutical companies and sponsors. The company receives compensation from sponsors for conducting studies. Study participants receive study-related medication, supplies, and testing at no charge, and are paid for each visit they attend.
2. Patient Care Services: Provides healthcare services including complimentary appointments with doctors, health screenings, and ongoing patient care. Services are offered at no charge to patients as part of clinical trial participation.

Go-to-market motion2 records

Distribution channels4 records

Marketing channels5 records

Core offering

Lucas Research is a clinical research site network that recruits participants and conducts clinical trials in endocrinology and metabolic disease for pharmaceutical sponsors and CROs. It runs studies on diabetes, fatty liver disease, obesity, arthritis, celiac disease, and cholesterol/triglyceride disorders across three North Carolina offices. The site also provides complimentary Fibroscan liver assessments and a patient portal as participant-facing services.

Product overview

Lucas Research is a clinical research site network founded by Dr. K. Jean Lucas in 2004, specializing in endocrinology-related clinical trials and metabolic disease research. The company operates as a unified clinical research platform offering three core services: clinical research studies for conditions including fatty liver, cholesterol/triglycerides, celiac disease, diabetes, arthritis, and obesity; Fibroscan liver diagnostic imaging services; and a patient portal for participant management. The company primarily serves the pharmaceutical industry and local communities in North Carolina, recruiting volunteer participants for clinical trials investigating new medications and treatment approaches.

Differentiator

Problem solved

Functional benefit

Products and services

• Clinical Research Studies Clinical research trials for medical conditions including fatty liver disease, cholesterol/triglycerides, celiac disease, diabetes, arthritis, obesity, and related metabolic disorders. Studies are conducted on behalf of pharmaceutical sponsors and CROs for adult participants meeting protocol criteria.
• Fibroscan Liver Scan Non-invasive liver health assessment using ultrasound-based transient elastography to measure liver stiffness and fat content, offered free to patients and study participants to evaluate liver condition without needles or painful procedures.
• Patient Portal Secure online patient portal that allows research participants to access their health information, manage appointments, and communicate with the Lucas Research care team.

Quantifiable outcome

• Dr. Lucas has conducted over 250 clinical research studies

Segments4 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

Two partnerships are on record, tiered core.

• Pharmaceutical SponsorscoreStrategic or Co-development PartnerLucas Research serves as a clinical trial site conducting studies on behalf of pharmaceutical companies. These partnerships involve executing clinical protocols for new drug development across metabolic and endocrine conditions.
• Contract Research Organizations (CROs)coreStrategic or Co-development PartnerPartnerships with CROs who manage clinical trial operations and delegate site responsibilities to Lucas Research for patient recruitment and study execution.

Scale indicators1 record

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Velocity Clinical Research: One of the largest US clinical trial site networks, operating integrated research sites across multiple therapeutic areas. Comparable to Lucas Research as a multi-site clinical research operator serving pharma sponsors, but at significantly greater scale and geographic reach.
• Elligo Health Research: National clinical research site network leveraging electronic health records and a "Research Ready" model to expand trial access. Directly comparable to Lucas Research as a site network serving pharma sponsors, but operating at national scale with technology-enabled patient identification.

Direct peers

• Meridien Research: Independent clinical research site network operating across the Southeastern US, conducting trials in metabolic, endocrine, and other therapeutic areas. Closely comparable to Lucas Research in size, regional footprint, and metabolic/endocrine specialization.
• Accel Research Sites: Multi-therapeutic clinical trial site network operating across the Southeastern US with multiple locations. Highly comparable to Lucas Research in operating model (independent site network serving pharma sponsors), therapeutic breadth, and US regional focus.
• Flourish Research: Multi-site clinical research organization operating across the US with strong metabolic, endocrine, and cardiology trial capabilities. Comparable to Lucas Research as a multi-site CRO serving pharma sponsors in therapeutic areas where Lucas specializes.
• National Research Institute: Multi-site clinical research organization with metabolic, endocrine, and GI therapeutic expertise. Comparable to Lucas Research as an independent site network executing trials in the same therapeutic categories.
• Hassman Research Institute: Independent clinical research site in New Jersey conducting endocrinology and metabolic disease trials with a long-tenured principal investigator. Closely comparable to Lucas Research as a PI-led, founder-driven site specializing in metabolic/endocrine trials.
• Drug Studies America: Independent multi-therapeutic clinical research site network. Comparable to Lucas Research as a US-based site network serving pharma sponsors across multiple chronic disease indications.
• Research Institute of Dallas: Independent clinical research site in Texas with metabolic, endocrine, and internal medicine trial expertise. Comparable to Lucas Research as a founder/PI-led specialty site network with a community-focused recruitment model.

Regional players

• Innovative Research of West Florida: Independent clinical research site on the Gulf Coast operating in similar chronic disease and metabolic indications. Comparable to Lucas Research in site operating model and therapeutic focus, but serving a different regional patient base.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/LucasResearch
• LinkedInlinkedin.com/company/lucas-research
• Instagraminstagram.com/lucasresearch

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Lucas Research